Blood is a precious but limited resource. Although very safe, the use of blood carries inherent risks and there is strong evidence associating blood transfusion with adverse outcomes including increased morbidity, mortality and length of stay.
To address these issues, Blood Watch is committed to supporting the sustainable, responsible, safe and appropriate use of blood and blood products.
The CEC implemented the Blood Watch program in 2005. In the initial stages of the program, key focus areas included appropriate use of red cells, establishment of local and state clinical governance frameworks, standardisation of education and other resources, and implementation of clinician engagement and communication strategies.
These areas remain as components of the program which is expanding to incorporate other important areas related to transfusion practice. The program framework includes safety, quality of the system, quality care, and efficiency.
Through a collaborative approach, the program provides leadership and support in quality care, clinical safety and supply security of blood and blood products to achieve world class transfusion medicine practice in NSW
Blood Watch key partners include clinicians and health care workers, local health districts and specialty networks, the NSW Ministry of Health, the Australian Red Cross Blood Service, NSW Health Pathology and the National Blood Authority.